GLP-1s have become the newest celebrity miracle drug, with famous athletes like Serena Williams and Charles Barkley sharing that they’ve used it for weight loss. Drugs like Ozempic and Wegovy have become a status symbol. But before they were famous, GLP-1s were developed to treat Type 2 diabetes, a disease that occurs when a person’s blood sugar becomes too high. It affects nearly 40 million Americans and hits Black Americans especially hard. According to the CDC, about 12 percent of Black adults have diabetes, compared with roughly 7 percent of white adults. Yet when researchers rev...
Why are fewer Black Americans getting GLP-1s?
HALO Observer Insight
An independent HALO consumer takeaway — for costs, wellness, or policy context — will appear here automatically for this story. HALO adds this original editorial insight to every syndicated report before publication.
Contributors
Wayne G Fraser
HALO Contributor
Insurance Broker
Insurance Industry
State
Georgia, North Carolina, South Carolina
NPN
17934945